Last updated 24 days ago

A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary Fibrosis

1092 patients around the world
Available in Spain, Colombia, United States, Chile, Peru, Brazil, Argentina, Mexico
Bristol-Myers Squibb
1092Patients around the world
This study is for people with
Pulmonary fibrosis
Requirements for the patient
From 21 Years
All Gender
Medical requirements
Trialtech
About usOur missionOur teamPartnersFAQs
Medical newsLatest newsStudiesInterviewsTestimonials
ProductsUEPM OncoUEPM Physicians
LinksDownloads
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy